Design, synthesis, and biological evaluation of novel dual inhibitors targeting lysine specific demethylase 1 (LSD1) and histone deacetylases (HDAC) for treatment of gastric cancer-Reference-Cited by-同舟云学术

Design, synthesis, and biological evaluation of novel dual inhibitors targeting lysine specific demethylase 1 (LSD1) and histone deacetylases (HDAC) for treatment of gastric cancer

Published:2021-08 Issue: Volume:220 Page:113453
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Duan Ying-Chao,Jin Lin-Feng,Ren Hong-Mei,Zhang Shao-Jie,Liu Yue-Jiao,Xu Yong-Tao,He Zi-Hao,Song Yu,Yuan Hang,Chen Shu-Hui,Guan Yuan-Yuan

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference65 articles.

1. Targeting epigenetic regulators for cancer therapy: modulation of bromodomain proteins, methyltransferases, demethylases, and microRNAs;Gelato;Expert Opin. Ther. Targets.,2016

2. Epigenetic therapies for cancer;Bates;N. Engl. J. Med.,2020

3. Genetics meets DNA methylation in rare diseases;Velasco;Clin. Genet.,2019

4. Two-hit wonders: the expanding universe of multitargeting epigenetic agents;de Lera;Curr. Opin. Chem. Biol.,2020

5. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1;Shi;Cell,2004

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overview of class I HDAC modulators: Inhibitors and degraders;European Journal of Medicinal Chemistry;2024-10

2. Advances in dual-targeting inhibitors of HDAC6 for cancer treatment;European Journal of Medicinal Chemistry;2024-09

3. Advances in SHP2 tunnel allosteric inhibitors and bifunctional molecules;European Journal of Medicinal Chemistry;2024-09

4. Design, synthesis, and evaluation of a novel TRAIL-activated HDAC6 inhibitor for the treatment of pulmonary fibrosis;Bioorganic & Medicinal Chemistry;2024-09

5. Research progress of LSD1-based dual-target agents for cancer therapy;Bioorganic & Medicinal Chemistry;2024-03